IP Library Granted Patent US 11,116,867
Granted Patent B1
US 11,116,867 · App. 16/034,695 · Granted Sep 14, 2021

Resorbable embolization spheres

Inventors: Stephen Penegor (Watertown, MN); Jason Isenburg (Victoria, MN); James Murto (Maple Grove, MN)
Assignee: TELEFLEX LIFE SCIENCES LIMITED
A61L24/104A61L24/0015A61L24/0042A61L2300/416A61L2400/06A61L2430/36
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,116,867
App. No.
16/034,695
Granted
Sep 14, 2021
Kind
B1
Abstract

Embolic materials, suspensions, kits and related methods useful for embolization are disclosed. An embolic material can comprise a resorbable microsphere including cross-linked gelatin as its primary ingredient and having a substantially spherical shape with a diameter of about 50 micrometers to about 1,500 micrometers, inclusive. The microsphere can optionally include one or both of a marker or an active agent. The microsphere can be cross-linked, such as with glutaraldehyde or formaldehyde, which can affect the microsphere's in vivo degradation profile and ability to withstand a sterilization process at certain temperatures. In an embodiment, the microspheres can resorb during an in vivo time period of between about 24 hours and about 15 weeks, inclusive. An embolization suspension can include a plurality of resorbable microspheres and a liquid carrier, and the suspension can be disposed in a syringe, vial or other applicator for administration to a patient.

Claims (24)

1. An embolic material, comprising:

resorbable microspheres formed from a sonicated solution of gelatin and water, wherein the sonicated solution comprises between at least 12% and up to 22% gelatin, wherein the microspheres are each free of air and have a substantially spherical shape reinforced by cross-linking the gelatin with glutaraldehyde or formaldehyde,

wherein the microspheres each include a radioactive agent, and

wherein the microspheres are unconnected and resistant to aggregation.

2. The embolic material of claim 1 , wherein each of the microspheres includes a marker.

3. The embolic material of claim 1 , wherein each of the microspheres is compressible.

4. The embolic material of claim 3 , wherein each of the microspheres resorbs during an in vivo time period of between about 24 hours and 15 weeks, inclusive.

5. The embolic material of claim 1 , wherein the radioactive agent comprises strontium, rhenium, yttrium, technetium, cobalt, or a combination thereof.

6. The embolic material of claim 1 , wherein each of the microspheres further comprises a prophylactic agent, a therapeutic agent, a diagnostic agent, or a combination thereof.

7. An embolic material, comprising:

resorbable microspheres formed from a sonicated solution of water and gelatin,

wherein the sonicated solution comprises between at least 12% and up to 22% gelatin,

wherein the microspheres are each free of air and have a substantially spherical shape reinforced by cross-linking the gelatin with glutaraldehyde or formaldehyde, and

wherein the microspheres are unconnected and resistant to aggregation.

8. The embolic material of claim 7 , wherein each of the microspheres further includes a marker.

9. The embolic material of claim 7 , wherein each of the microspheres further includes a radioactive agent comprising strontium, rhenium, yttrium, technetium, cobalt, or a combination thereof.

10. The embolic material of claim 7 , wherein each of the microspheres further includes a prophylactic agent, a therapeutic agent, a diagnostic agent, or a combination thereof.

11. A kit comprising:

an effective amount of an injectable embolization suspension disposed in a pre-loaded applicator;

wherein the suspension includes a liquid carrier and the resorbable microspheres of claim 1 ; and

wherein the microspheres are suitable for embolization.

12. The kit of claim 11 , further comprising a delivery catheter that can be placed into a lumen.

13. The kit of claim 11 , wherein each of the microspheres includes a marker.

14. The kit of claim 11 , wherein the radioactive agent comprises strontium, rhenium, yttrium, technetium, cobalt, or a combination thereof.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2024
From: TELEFLEX LIFE SCIENCES LIMITED
To: TELEFLEX LIFE SCIENCES III LLC
Reel/Frame 066305/0565 →
MERGER Recorded Jan 15, 2024
From: TELEFLEX LIFE SCIENCES III LLC
To: TELEFLEX LIFE SCIENCES LLC
Reel/Frame 066305/0817 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2020
From: TELEFLEX INNOVATIONS S.À.R.L.
To: TELEFLEX MEDICAL DEVICES S.À.R.L.
Reel/Frame 051519/0816 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2020
From: TELEFLEX MEDICAL DEVICES S.À.R.L.
To: TELEFLEX LIFE SCIENCES LIMITED
Reel/Frame 051519/0873 →
CHANGE OF NAME Recorded Aug 7, 2018
From: VASCULAR SOLUTIONS, INC.
To: VASCULAR SOLUTIONS LLC
Reel/Frame 046733/0343 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2018
From: VASCULAR SOLUTIONS LLC
To: TELEFLEX INNOVATIONS S.À.R.L.
Reel/Frame 046733/0367 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2018
From: PENEGOR, STEPHEN; ISENBURG, JASON; MURTO, JAMES
To: VASCULAR SOLUTIONS, INC.
Reel/Frame 046570/0773 →
Continuity (3)
Continuation 15664358 · Jul 31, 2017
Division 15131534 · Apr 18, 2016
Provisional Application 62148889 · Apr 17, 2015